Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
50 studies found for:    s1117
Show Display Options
Rank Status Study
1 Active, not recruiting Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia;   de Novo Myelodysplastic Syndrome;   Previously Treated Myelodysplastic Syndrome;   Refractory Anemia With Excess Blasts;   Secondary Myelodysplastic Syndrome
Interventions: Drug: Azacitidine;   Drug: Lenalidomide;   Drug: Vorinostat
2 Completed BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: Interferon beta-1b (Betaferon/Betaseron, BAY86-5046);   Drug: Copaxone
3 Completed
Has Results
BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Interferon beta-1b (Betaseron, BAY86-5046)
4 Completed Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)
Condition: Asthma
Intervention: Drug: Ciclesonide
5 Completed Effect of Ciclesonide on Quality of Life in Patients With Moderate Persistent Asthma (21 to 65 y) (BY9010/AR-101)
Condition: Asthma
Intervention: Drug: Ciclesonide
6 Completed Efficacy of NNC109-0012 in Subjects With Active Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis;   Inflammation
Interventions: Drug: NNC109-0012;   Drug: placebo
7 Active, not recruiting This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Condition: Bipolar I Disorder
Intervention: Drug: Lurasidone
8 Completed Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors
Condition: Advance Solid Tumors
Interventions: Drug: Iniparib (SAR240550 - BSI-201);   Drug: Gemcitabine;   Drug: Carboplatin
9 Completed Relapse-prevention Study With Lu AA21004 in Patients With Generalized Anxiety Disorder
Condition: Generalized Anxiety Disorder
Interventions: Drug: Lu AA21004;   Drug: Placebo
10 Completed A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307)
Condition: Schizophrenia
Interventions: Drug: Placebo;   Drug: RO4917838
11 Completed Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: insulin aspart;   Drug: insulin human
12 Completed Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Intervention: Drug: IDegAsp
13 Active, not recruiting Safety and Efficacy of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Paediatric Subjects With Congenital Factor XIII A-subunit Deficiency
Conditions: Congenital Bleeding Disorder;   Congenital FXIII Deficiency
Intervention: Drug: catridecacog
14 Completed Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Intervention: Drug: insulin degludec
15 Completed
Has Results
Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents
Conditions: Growth Hormone Disorder;   Growth Hormone Deficiency in Children;   Foetal Growth Problem;   Small for Gestational Age;   Genetic Disorder;   Turner Syndrome;   Chronic Kidney Disease;   Chronic Renal Insufficiency;   Delivery Systems
Intervention: Drug: Norditropin NordiFlex®
16 Completed Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel
17 Completed
Has Results
Prevention of Recurrence of Diverticulitis
Condition: Diverticulitis
Interventions: Drug: SPD476 (1.2g);   Drug: SPD476 (2.4 g);   Drug: SPD476 (4.8 g);   Drug: Placebo
18 Unknown  Prophylaxis of Thromboembolic Complications Trial: Thromboprophylaxis Needed in Below Knee Plaster Cast Immobilization for Ankle and Foot Fractures
Conditions: Deep Vein Thrombosis;   Pulmonary Embolism
Interventions: Drug: Nadroparin;   Drug: Fondaparinux
19 Active, not recruiting A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
Condition: Cardiovascular Disease, Rheumatoid Arthritis
Interventions: Drug: etanercept;   Drug: tocilizumab [RoActemra/Actemra]
20 Completed Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL)
Condition: Osteoporosis
Interventions: Drug: lasofoxifene;   Other: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years